Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 CAD | 0.00% | 0.00% | +20.00% |
Feb. 28 | NAVCO Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,350,441 | 39,946,936 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Navco Pharmaceuticals, Inc.
1050 West Georgia Street Suite 1500
V6E 4N7, Vancouver
+
Sector
1st Jan change | Capi. | |
---|---|---|
+20.00% | 1.26M | |
+14.43% | 395B | |
+12.58% | 142B | |
+18.89% | 77.44B | |
-13.26% | 65.65B | |
-10.32% | 47.02B | |
-8.06% | 38.1B | |
+7.77% | 35.33B | |
+11.44% | 18.36B | |
+13.41% | 15.96B |
- Stock Market
- Equities
- NAV Stock
- Company NAVCO Pharmaceuticals Inc.